Susceptibility of proliferating cytolytic T lymphocytes to 33258 Hoechst-modified BUdR and light treatment: quantitation of the residual precursor cells by limiting dilution analysis.
D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D006690:Bisbenzimidazole / Q000494:pharmacology*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002455:Cell Division; D003602:Cytotoxicity, Immunologic; D004247:DNA / Q000096:biosynthesis; D008027:Light; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D013601:T-Lymphocytes / Q000166:cytology*; D013997:Time Factors
D001562:Benzimidazoles; D004247:DNA; D001973:Bromodeoxyuridine; D006690:Bisbenzimidazole